Home | About JCVJS | Editorial board | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |   Login 
Journal of Craniovertebral Junction and Spine
Search Articles   
Advanced search   

    Article Cited by others


Use of recombinant human bone morphogenetic protein-2 as an adjunct for instrumented posterior arthrodesis in the occipital cervical region: An analysis of safety, efficacy, and dosing

Hamilton D Kojo, Smith Justin S, Reames Davis L, Williams Brian J, Shaffrey Christopher I

Year : 2010| Volume: 1| Issue : 2 | Page no: 107-112

   This article has been cited by
1 Letter: Reconsidering Bone Morphogenetic Protein in the Cervical Spine: Selective Use for Managing Type II Odontoid Fractures in the Elderly
Francis J Jareczek, Kingsley O Abode-Iyamah, Efrem M Cox, Nader S Dahdaleh, Patrick W Hitchon, Matthew A Howard
Operative Neurosurgery. 2017; 13(6): E39
[Pubmed]  [Google Scholar] [DOI]
2 Cancer After Spinal Fusion
Shivanand P. Lad,Jacob H. Bagley,Isaac O. Karikari,Ranjith Babu,Beatrice Ugiliweneza,Maiying Kong,Robert E. Isaacs,Carlos A. Bagley,Oren N. Gottfried,Chirag G. Patil,Maxwell Boakye
Neurosurgery. 2013; 73(3): 440
[Pubmed]  [Google Scholar] [DOI]
3 The concern on clinical use of recombinant human bone morphogenetic protein-2
Wiwanitkit, V.
Journal of Craniovertebral Junction and Spine. 2011; 2(2): 102-103
[Pubmed]  [Google Scholar]


Read this article